Global Immunity Nutraceutical Ingredient Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Immunity Nutraceutical Ingredient market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Immunity Nutraceutical Ingredient is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Immunity Nutraceutical Ingredient is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Immunity Nutraceutical Ingredient is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Immunity Nutraceutical Ingredient is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Immunity Nutraceutical Ingredient include Tate & Lyle PLC (U.K), Koninklijke DSM N.V. (Netherlands), Ingredion Incorporated (U.S), Arla Foods (Denmark) and Ajinomoto Co., Inc. (Japan), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Immunity Nutraceutical Ingredient, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Immunity Nutraceutical Ingredient, also provides the sales of main regions and countries. Of the upcoming market potential for Immunity Nutraceutical Ingredient, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immunity Nutraceutical Ingredient sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Immunity Nutraceutical Ingredient market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Immunity Nutraceutical Ingredient sales, projected growth trends, production technology, application and end-user industry.


Immunity Nutraceutical Ingredient Segment by Company

Tate & Lyle PLC (U.K)
Koninklijke DSM N.V. (Netherlands)
Ingredion Incorporated (U.S)
Arla Foods (Denmark)
Ajinomoto Co., Inc. (Japan)

Immunity Nutraceutical Ingredient Segment by Type

Carotenoids
Minerals
Omega-3 fatty acids
Fibers & specialty carbohydrates
Phytochemical and plant extracts
Others

Immunity Nutraceutical Ingredient Segment by Application

Dietary supplements
Functional beverages
Functional food
Personal care
Animal nutrition

Immunity Nutraceutical Ingredient Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunity Nutraceutical Ingredient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunity Nutraceutical Ingredient and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunity Nutraceutical Ingredient.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immunity Nutraceutical Ingredient market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunity Nutraceutical Ingredient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immunity Nutraceutical Ingredient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Immunity Nutraceutical Ingredient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Immunity Nutraceutical Ingredient Market Size, 2020 VS 2024 VS 2031
1.3 Global Immunity Nutraceutical Ingredient Market Size Estimates and Forecasts (2020-2031)
1.4 Global Immunity Nutraceutical Ingredient Sales Estimates and Forecasts (2020-2031)
1.5 Global Immunity Nutraceutical Ingredient Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Immunity Nutraceutical Ingredient Market Dynamics
2.1 Immunity Nutraceutical Ingredient Industry Trends
2.2 Immunity Nutraceutical Ingredient Industry Drivers
2.3 Immunity Nutraceutical Ingredient Industry Opportunities and Challenges
2.4 Immunity Nutraceutical Ingredient Industry Restraints
3 Immunity Nutraceutical Ingredient Market by Manufacturers
3.1 Global Immunity Nutraceutical Ingredient Revenue by Manufacturers (2020-2025)
3.2 Global Immunity Nutraceutical Ingredient Sales by Manufacturers (2020-2025)
3.3 Global Immunity Nutraceutical Ingredient Average Sales Price by Manufacturers (2020-2025)
3.4 Global Immunity Nutraceutical Ingredient Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Immunity Nutraceutical Ingredient Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Immunity Nutraceutical Ingredient Manufacturers, Product Type & Application
3.7 Global Immunity Nutraceutical Ingredient Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Immunity Nutraceutical Ingredient Market CR5 and HHI
3.8.2 Global Top 5 and 10 Immunity Nutraceutical Ingredient Players Market Share by Revenue in 2024
3.8.3 2024 Immunity Nutraceutical Ingredient Tier 1, Tier 2, and Tier 3
4 Immunity Nutraceutical Ingredient Market by Type
4.1 Immunity Nutraceutical Ingredient Type Introduction
4.1.1 Carotenoids
4.1.2 Minerals
4.1.3 Omega-3 fatty acids
4.1.4 Fibers & specialty carbohydrates
4.1.5 Phytochemical and plant extracts
4.1.6 Others
4.2 Global Immunity Nutraceutical Ingredient Sales by Type
4.2.1 Global Immunity Nutraceutical Ingredient Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Immunity Nutraceutical Ingredient Sales by Type (2020-2031)
4.2.3 Global Immunity Nutraceutical Ingredient Sales Market Share by Type (2020-2031)
4.3 Global Immunity Nutraceutical Ingredient Revenue by Type
4.3.1 Global Immunity Nutraceutical Ingredient Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Immunity Nutraceutical Ingredient Revenue by Type (2020-2031)
4.3.3 Global Immunity Nutraceutical Ingredient Revenue Market Share by Type (2020-2031)
5 Immunity Nutraceutical Ingredient Market by Application
5.1 Immunity Nutraceutical Ingredient Application Introduction
5.1.1 Dietary supplements
5.1.2 Functional beverages
5.1.3 Functional food
5.1.4 Personal care
5.1.5 Animal nutrition
5.2 Global Immunity Nutraceutical Ingredient Sales by Application
5.2.1 Global Immunity Nutraceutical Ingredient Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Immunity Nutraceutical Ingredient Sales by Application (2020-2031)
5.2.3 Global Immunity Nutraceutical Ingredient Sales Market Share by Application (2020-2031)
5.3 Global Immunity Nutraceutical Ingredient Revenue by Application
5.3.1 Global Immunity Nutraceutical Ingredient Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Immunity Nutraceutical Ingredient Revenue by Application (2020-2031)
5.3.3 Global Immunity Nutraceutical Ingredient Revenue Market Share by Application (2020-2031)
6 Global Immunity Nutraceutical Ingredient Sales by Region
6.1 Global Immunity Nutraceutical Ingredient Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Immunity Nutraceutical Ingredient Sales by Region (2020-2031)
6.2.1 Global Immunity Nutraceutical Ingredient Sales by Region (2020-2025)
6.2.2 Global Immunity Nutraceutical Ingredient Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Immunity Nutraceutical Ingredient Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Immunity Nutraceutical Ingredient Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Immunity Nutraceutical Ingredient Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Immunity Nutraceutical Ingredient Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Immunity Nutraceutical Ingredient Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Immunity Nutraceutical Ingredient Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Immunity Nutraceutical Ingredient Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Immunity Nutraceutical Ingredient Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Immunity Nutraceutical Ingredient Revenue by Region
7.1 Global Immunity Nutraceutical Ingredient Revenue by Region
7.1.1 Global Immunity Nutraceutical Ingredient Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Immunity Nutraceutical Ingredient Revenue by Region (2020-2025)
7.1.3 Global Immunity Nutraceutical Ingredient Revenue by Region (2026-2031)
7.1.4 Global Immunity Nutraceutical Ingredient Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Immunity Nutraceutical Ingredient Revenue (2020-2031)
7.2.2 North America Immunity Nutraceutical Ingredient Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Immunity Nutraceutical Ingredient Revenue (2020-2031)
7.3.2 Europe Immunity Nutraceutical Ingredient Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Immunity Nutraceutical Ingredient Revenue (2020-2031)
7.4.2 Asia-Pacific Immunity Nutraceutical Ingredient Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Immunity Nutraceutical Ingredient Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Immunity Nutraceutical Ingredient Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Tate & Lyle PLC (U.K)
8.1.1 Tate & Lyle PLC (U.K) Comapny Information
8.1.2 Tate & Lyle PLC (U.K) Business Overview
8.1.3 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Product Portfolio
8.1.5 Tate & Lyle PLC (U.K) Recent Developments
8.2 Koninklijke DSM N.V. (Netherlands)
8.2.1 Koninklijke DSM N.V. (Netherlands) Comapny Information
8.2.2 Koninklijke DSM N.V. (Netherlands) Business Overview
8.2.3 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Product Portfolio
8.2.5 Koninklijke DSM N.V. (Netherlands) Recent Developments
8.3 Ingredion Incorporated (U.S)
8.3.1 Ingredion Incorporated (U.S) Comapny Information
8.3.2 Ingredion Incorporated (U.S) Business Overview
8.3.3 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Product Portfolio
8.3.5 Ingredion Incorporated (U.S) Recent Developments
8.4 Arla Foods (Denmark)
8.4.1 Arla Foods (Denmark) Comapny Information
8.4.2 Arla Foods (Denmark) Business Overview
8.4.3 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Product Portfolio
8.4.5 Arla Foods (Denmark) Recent Developments
8.5 Ajinomoto Co., Inc. (Japan)
8.5.1 Ajinomoto Co., Inc. (Japan) Comapny Information
8.5.2 Ajinomoto Co., Inc. (Japan) Business Overview
8.5.3 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Product Portfolio
8.5.5 Ajinomoto Co., Inc. (Japan) Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Immunity Nutraceutical Ingredient Value Chain Analysis
9.1.1 Immunity Nutraceutical Ingredient Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Immunity Nutraceutical Ingredient Production Mode & Process
9.2 Immunity Nutraceutical Ingredient Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Immunity Nutraceutical Ingredient Distributors
9.2.3 Immunity Nutraceutical Ingredient Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings